Investor Presentaiton

ANDA Pipeline - Significant ramp up ANDAS Filed and Approved SUN PHARMA 445 ANDA Approvals by Therapeutic Area 597 599 106 98 478 449 438 445 397 377 344 311 250 225 207 84 FY10 FY11 FY12 FY13 FY14 FY15 Sep-15 Cumulative Products Filed Cumulative Products Approved (Taro numbers added since Mar 2011, URL numbers added since Mar 2013 & Ranbaxy numbers added for March'15) Sun Pharmaceutical Industries Limited. All Rights Reserved. 61 Pain 40 40 34 30 50 20 20 13 13 30 30 Antibiotic Allergy Oncology Gastro Metabolism Other (As of Sept'15) 19

View entire presentation